News Updates
More Articles
- Smallpox vaccine demand surges due to monkeypox outbreak
- Switzerland signs contract with Pfizer for Paxlovid
- CHMP backs Lilly's baracitinib for alopecia areata
- EU OKs Chikungunya virus tests from BioMerieux
- Merck, Kelun collaborate on cancer project worth $1.4B
Smallpox vaccine demand surges due to monkeypox outbreak
The spread of the monkeypox virus globally has stoked the demand for a smallpox vaccine made by Bavarian Nordic, known under the brand name Jynneos in the US. There is currently no vaccine for monkeypox but studies have found Jynneos to prevent the disease by at least 85% since the virus is closely related to smallpox. The Wall Street Journal (5/24)
Read full article now.
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!